Article Text

Download PDFPDF
De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features
  1. Oddmund Søvik1,
  2. Suzanne Schubbert2,*,
  3. Gunnar Houge3,*,
  4. Solrun J Steine4,
  5. Gunnar Norgård5,
  6. Bernt Engelsen6,
  7. Pål R Njølstad1,5,
  8. Kevin Shannon2,
  9. Anders Molven7
  1. 1Section for Pediatrics, Department of Clinical Medicine, University of Bergen, Bergen, Norway
  2. 2Department of Pediatrics, University of California, San Fransisco, CA, USA
  3. 3Department of Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
  4. 4Section for Pathology, the Gade Institute, University of Bergen, Bergen, Norway
  5. 5Department of Pediatrics, Haukeland University Hospital, Bergen, Norway
  6. 6Department of Neurology, Haukeland University Hospital, Bergen, Norway
  7. 7Department of Pathology, Haukeland University Hospital, Bergen, Norway
  1. Correspondence to:
 Professor A Molven
 Section for Pathology, the Gade Institute, University of Bergen, Haukeland University Hospital, N-5021 Bergen, Norway; anders.molven{at}


Mutations in genes involved in Ras signalling cause Noonan syndrome and other disorders characterised by growth disturbances and variable neuro-cardio-facio-cutaneous features. We describe two sisters, 46 and 31 years old, who presented with dysmorphic features, hypotonia, feeding difficulties, retarded growth and psychomotor retardation early in life. The patients were initially diagnosed with Costello syndrome, and autosomal recessive inheritance was assumed. Remarkably, however, we identified a germline HRAS mutation (G12A) in one sister and a germline KRAS mutation (F156L) in her sibling. Both mutations had arisen de novo. The F156L mutant K-Ras protein accumulated in the active, guanosine triphosphate-bound conformation and affected downstream signalling. The patient harbouring this mutation was followed for three decades, and her cardiac hypertrophy gradually normalised. However, she developed severe epilepsy with hippocampal sclerosis and atrophy. The occurrence of distinct de novo mutations adds to variable expressivity and gonadal mosaicism as possible explanations of how an autosomal dominant disease may manifest as an apparently recessive condition.

  • CFC, cardio-facio-cutaneous
  • CS, Costello’s syndrome
  • GTP, guanosine triphosphate
  • MAPK, mitogen-activated protein kinase
  • NF1, neurofibromatosis type 1
  • NS, Noonan’s syndrome
  • SNP, single nucleotide polymorphism
  • Costello syndrome
  • cardio-facio-cutaneous syndrome
  • Noonan syndrome
  • MAPK signalling pathway
  • Ras genes

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding: This work was supported by grants from the Research Council of Norway and the Meltzer Foundation to O Søvik, from Helse Vest and the University of Bergen to A Molven and P R Njølstad, and by NIH grants R01 CA72614 and R01 CA104282 to K Shannon.

  • Competing interests: None declared.

  • * The second and third authors contributed equally to this work.

    Parental informed consent was obtained for publication of figure 1.